2016

10930 bookmarks
Custom sorting
Parkinson’s Disease Education - YouTube
Parkinson’s Disease Education - YouTube
This channel is dedicated to helping Persons with Parkinson's Disease to become Parkinson's Warriors fighting their disease wielding the weapon of knowledge about PD and the impact that it has on daily living. Book 1:1 consultation with a Parkinson's Disease Expert here: https://clarity.fm/pdeducation Explore channel memberships here: YouTube: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join Patreon: https://www.patreon.com/pdeducation If you have products that you would like for me to review on the channel please send them here: Parkinson's Disease Education P.O. Box 1678 Broken Arrow, OK 74013
·youtube.com·
Parkinson’s Disease Education - YouTube
Parkinsons New Zealand - YouTube
Parkinsons New Zealand - YouTube
Parkinson's New Zealand provides information, education and support to people living with Parkinson's, care partners and healthcare professionals. Parkinson's is a progressive neurological condition which affects over 12,000 New Zealanders. Although it cannot be cured, treatment is available.
·youtube.com·
Parkinsons New Zealand - YouTube
Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition - Smith - 2025 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition - Smith - 2025 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
BACKGROUND Preclinical studies suggest that creatine monohydrate (CrM) improves cognition and Alzheimer's disease (AD) biomarkers. However, there is currently no clinical evidence demonstrating the ...
·alz-journals.onlinelibrary.wiley.com·
Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition - Smith - 2025 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
NEW STUDY: Creatine for Alzheimer's? - YouTube
NEW STUDY: Creatine for Alzheimer's? - YouTube
A just-published study provides new insight into creatine in the context of Alzheimers. For all the references/articles I cited, article is coming tomorrow!#...
·youtube.com·
NEW STUDY: Creatine for Alzheimer's? - YouTube
OmegaXL
OmegaXL
OmegaXL is a powerful natural supplement shown in clinical research to support joint comfort and function? It contains more than 30 healthy fatty acids, including DHA and EPA. Give it a try, OmegaXL works!
·omegaxl.com·
OmegaXL
Public Health Risks of PFAS-Related Immunotoxicity Are Real | Current Environmental Health Reports
Public Health Risks of PFAS-Related Immunotoxicity Are Real | Current Environmental Health Reports
Purpose of Review The discovery of per- and polyfluoroalkyl substances (PFAS) in the environment and humans worldwide has ignited scientific research, government inquiry, and public concern over numerous adverse health effects associated with PFAS exposure. In this review, we discuss the use of PFAS immunotoxicity data in regulatory and clinical decision-making contexts and question whether recent efforts adequately account for PFAS immunotoxicity in public health decision-making. Recent Findings Government and academic reviews confirm the strongest human evidence for PFAS immunotoxicity is reduced antibody production in response to vaccinations, particularly for tetanus and diphtheria. However, recent events, such as the economic analysis supporting the proposed national primary drinking water regulations and clinical monitoring recommendations, indicate a failure to adequately incorporate these data into regulatory and clinical decisions. Summary To be more protective of public health, we recommend using all relevant immunotoxicity data to inform current and future PFAS-related chemical risk assessment and regulation. Biological measures of immune system effects, such as reduced antibody levels in response to vaccination, should be used as valid and informative markers of health outcomes and risks associated with PFAS exposure. Routine toxicity testing should be expanded to include immunotoxicity evaluations in adult and developing organisms. In addition, clinical recommendations for PFAS-exposed individuals and communities should be revisited and strengthened to provide guidance on incorporating immune system monitoring and other actions that can be taken to protect against adverse health outcomes.
·link.springer.com·
Public Health Risks of PFAS-Related Immunotoxicity Are Real | Current Environmental Health Reports